NASDAQ:RDHL

Redhill Biopharma Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy RDHL

*Your capital is at risk

$1.00

-0.0100 (-0.99%)

At Close: Jun 03, 2026

Redhill Biopharma Stock Insider Power

Based on the 31 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 1.65B and sold 15.74M RDHL shares in the last 31 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 31 transactions)	100.00
● Buy	1.65B shares
● Sell	15.74M shares
97% Buy Activity Weak Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 06, 2026 Buy	American Depositary Shares M-Exempt	Raday Gilead Chief Operating Officer	C-Suite Officer	30 780 000 Value: $25.5M
Apr 06, 2026 Sell	Ordinary Shares S-Sale	Raday Gilead Chief Operating Officer	C-Suite Officer	15 740 000 Value: $2K
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Tsimchi Ofer Director	Director	180 000 Value: $152.0K
Mar 18, 2026 Buy	American Depositary Shares	Tsimchi Ofer Director	Director	36 440 000 Value: $30.8M
Mar 18, 2026 Buy	Ordinary Shares	Tsimchi Ofer Director	Director	0 Value: $0
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Reed Kenneth Director	Director	250 000 Value: $211.2K
Mar 18, 2026 Buy	Ordinary Shares	Raday Gilead Chief Operating Officer	C-Suite Officer	0 Value: $0
Mar 18, 2026 Buy	American Depositary Shares	Raday Gilead Chief Operating Officer	C-Suite Officer	45 370 000 Value: $38.3M
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Raday Gilead Chief Operating Officer	C-Suite Officer	180 000 Value: $152.0K
Mar 18, 2026 Buy	Ordinary Shares	Mamluk Roni Director	Director	0 Value: $0
Mar 18, 2026 Buy	American Depositary Shares	Mamluk Roni Director	Director	613 500 000 Value: $0.52B
Mar 18, 2026 Buy	Ordinary Shares	Ingber Razi Chief Financial Officer	C-Suite Officer	0 Value: $0
Mar 18, 2026 Buy	American Depositary Shares	Ingber Razi Chief Financial Officer	C-Suite Officer	66 910 000 Value: $56.5M
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Ingber Razi Chief Financial Officer	C-Suite Officer	230 000 Value: $194.3K
Mar 18, 2026 Buy	Ordinary Shares	Goldberg Guy Joel Chief Business Officer	Officer	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Scruggs Rick D Chief Commercial Officer	Officer	0 Value: $0
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Goldberg Guy Joel Chief Business Officer	Officer	600 000 Value: $506.8K
Mar 18, 2026 Buy	Ordinary Shares	Frish Adi Chief Corp & Bd Officer	Officer	0 Value: $0
Mar 18, 2026 Buy	American Depositary Shares	Frish Adi Chief Corp & Bd Officer	Officer	62 800 000 Value: $53.0M
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Frish Adi Chief Corp & Bd Officer	Officer	750 000 Value: $633.5K
Mar 18, 2026 Buy	Ordinary Shares	Cabilly Shmuel Director	Director	0 Value: $0
Mar 18, 2026 Buy	American Depositary Shares	Cabilly Shmuel Director	Director	30 630 000 Value: $25.9M
Mar 18, 2026 Buy	Stock Option (Right to Buy)	Cabilly Shmuel Director	Director	180 000 Value: $152.0K
Mar 18, 2026 Buy	Ordinary Shares	Ben-asher Dror Chief Executive Officer	CEO / President	0 Value: $0
Mar 18, 2026 Buy	American Depositary Shares	Ben-asher Dror Chief Executive Officer	CEO / President	103 360 000 Value: $87.3M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT REDHILL BIOPHARMA LTD.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development pr...

Read Full Profile Here